CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- 4 Open-market sale SVP, Gen. Counsel & Secretary sold 11,146 shares at $118.59 ($1,321,775)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes EVP,Finance & Strategy and CFO gave up 1,166 shares (to pay taxes)
- 4 Shares withheld for taxes President and COO gave up 2,826 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 4,917 shares (to pay taxes)
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement
- 8-K Event Results of operations · Other events
- 8-K Event Other events
- 4 Option exercise President and COO acquired 2,000 shares (option exercise)
- 4 Open-market sale President and COO sold 7,225 shares at $110.00 ($794,750)
- 10-K Report Annual Report
- 4 Shares withheld for taxes Chief Executive Officer gave up 10,125 shares (to pay taxes)
- 4 Open-market sale President and COO sold 7,225 shares at $95.84 ($692,467)
- 4 Shares withheld for taxes SVP, Gen. Counsel & Secretary gave up 881 shares (to pay taxes)
- 4 Grant or award EVP,Finance & Strategy and CFO acquired 6,848 shares (grant or award)
- SC 13G Stake Amended Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 30 of 115 · 2,300 filings